https://www.swissmedic.ch/dam/swissmedic/de/dokumente/marktueberwachung/mu/drug_exposure_duringpregnancyandparent-childreportsfromswitzerla.pdf.download.pdf/drug_exposure_duringpregnancyandparent-childreportsfromswitzerla.pdf
https://www.aemps.gob.es/investigacionClinica/medicamentos/docs/Instrucciones-realizacion-ensayos-clinicos.pdf
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-3-6-may-2021
https://www.ema.europa.eu/en/news/confidentiality-arrangement-between-eu-brazilian-regulatory-authorities
https://www.ema.europa.eu/en/documents/other/monitoring-medical-literature-entry-relevant-information-eudravigilance-database-european-medicines_en.pdf
Huit nouveaux médicaments recommandés pour approbation.
https://www.swissmedic.ch/swissmedic/fr/home/news/mitteilungen/info-elektronischen-meldungen-pharmacovigilance.html
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-union-individual-case-safety-report-icsr-implementation-guide_en.pdf
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-pre-authorisation-procedural-advice-users-centralised-procedure_en-0.pdf
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-6-9-april-2021